CareerPlan

Senior Scientist I/II, Hematology- Target Biology and Discovery

Cambridge (USA)Full-time$94k–$183k2026-10-28 → 2026-11-11
On-site · United States

Core

Identify and validate novel therapeutic targets and advance early drug-discovery programs for hematologic cancers, specifically myeloid malignancies like AML/MDS.

Role type

Senior Scientist I/II, Target Biology and Discovery

Builds

Early drug-discovery programs for hematologic malignancies

Domain

Biotechnology / Oncology / Hematology

Required skills

Molecular and cellular biology, CRISPR-based perturbation, gene knockdown/overexpression, chemical probes, western blotting, qPCR, imaging, cellular phenotyping, mammalian cell culture, multiparameter flow cytometry, assay development, experimental design

Preferred skills

Primary hematopoic or patient-derived samples, CRISPR-based functional genomics, high-throughput screening, pharmaceutical/biotech environment experience, AML/MDS knowledge

Technologies

CRISPR, qPCR, western blotting, flow cytometry

Responsibilities

Identify critical drug-discovery questions and develop experimental strategies; Conduct studies for target identification/validation/mechanism of action; Develop and optimize cellular assays; Establish disease-relevant hematologic models; Collaborate in multidisciplinary environments to prioritize hypotheses; Analyze datasets and communicate results

Seniority

Senior, hands-on IC